Business Context and Reporting Period
Company: James River Group Holdings, Inc. (formerly James River Group Holdings, Ltd.)
Filing Type: Form 10-Q
Reporting Period: Quarter and six months ended June 30, 2026
Key Corporate Event: On November 7, 2025, the Company completed a domestication from Bermuda to Delaware. This filing reflects the results of the Delaware entity following the domestication and the Bermuda entity prior to it.
Operations: The Company operates three segments: Excess & Surplus Lines (E&S), Specialty Admitted Insurance, and Corporate & Other. The former Casualty Reinsurance segment was sold in April 2024 and is reported as discontinued operations.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net Written Premiums | $268.5 million | $303.9 million |
| Net Earned Premiums | $274.7 million | $304.5 million |
| Net Investment Income | $41.6 million | $40.5 million |
| Net Realized/Unrealized Investment Gains (Losses) | $(5.6) million | $(1.7) million |
| Net Income (Loss) from Continuing Operations | $(2.2) million | $16.1 million |
| Net Income (Loss) Available to Common Shareholders | $(6.5) million | $10.4 million |
| Underwriting Profit (Loss) | $(6.5) million | $2.8 million |
| Combined Ratio | 102.4% | 99.1% |
| Total Assets | $4.77 billion | $4.86 billion |
| Total Liabilities | $4.12 billion | $4.19 billion |
| Shareholders' Equity | $522.6 million | $538.2 million |
| Senior Debt Outstanding | $225.8 million | $225.8 million |
| Cash and Cash Equivalents | $195.6 million | $260.9 million |
Material Changes vs. Prior Period
- Premium Volume Decline: Gross written premiums decreased 24.9% year-over-year to $505.3 million. The Specialty Admitted Insurance segment saw a 73.0% decline due to program non-renewals, while the E&S segment declined 10.0% due to competitive market conditions.
- Underwriting Loss: The Company reported an underwriting loss of $6.5 million (Combined Ratio 102.4%) compared to a profit of $2.8 million (Combined Ratio 99.1%) in the prior year. This was driven by a higher expense ratio (34.6% vs. 31.7%) due to lower premium volume and lower ceding commissions, partially offset by a stable loss ratio.
- Investment Volatility: Net realized and unrealized investment losses widened to $5.6 million from $1.7 million, primarily due to $4.6 million in losses on bank loan participations and $0.8 million on equity securities.
- Net Loss: The Company reported a net loss of $2.5 million for the six months ended June 30, 2026, compared to net income of $14.3 million in the prior year period.
- Reserve Development: Net adverse reserve development on prior accident years was $0.4 million for the six months ended June 30, 2026, an improvement from $2.9 million in the prior year period.
Guidance, Outlook, Risks, and Unusual Items
- Goodwill Impairment Risk: Management performed a quantitative goodwill impairment test in Q2 2026 due to a sustained decline in stock price. While no impairment was recorded, the fair value of the E&S reporting unit exceeded its carrying value by less than 3%, a significant reduction from the previous cushion. Further declines in stock price or market conditions could trigger an impairment charge.
- Retroactive Reinsurance Exhaustion: The "E&S Top Up ADC" adverse development cover, which had a $75.0 million limit, was fully exhausted in the six months ended June 30, 2026. The "E&S ADC" limit was exhausted in 2025. The Company now has limited protection against adverse development on legacy books.
- Legal Proceedings: Ongoing litigation with Fleming Intermediate Holdings LLC regarding the sale of JRG Re continues. The Company is defending against claims for damages, and the outcome remains uncertain.
- Reinsurance Capacity: The Company faces risks regarding the availability and cost of reinsurance. Some treaties have loss ratio caps or aggregate limits that could be exceeded, leaving the Company exposed to losses.
- Domestication Tax Impact: The 2025 domestication resulted in a one-time tax benefit of $14.1 million related to business interest expense deductions, which lowered the effective tax rate for the six months ended June 30, 2026 to 0.9%.
Investor Verification Checklist
- Goodwill Valuation: Verify the assumptions used in the goodwill impairment test, given the narrow margin of safety (less than 3%) and the sensitivity to stock price fluctuations.
- Reinsurance Exposure: Assess the Company's exposure to adverse loss development on legacy books now that the E&S Top Up ADC and E&S ADC limits are exhausted.
- Investment Portfolio Quality: Review the credit quality of the bank loan participations portfolio, which contributed significantly to investment losses, and the extent of unrealized losses in fixed maturity securities ($61.5 million).
- Specialty Admitted Segment Strategy: Evaluate the long-term strategy for the Specialty Admitted Insurance segment following the 73% decline in premiums and continued underwriting losses.
- Liquidity Position: Confirm the Company's ability to meet debt covenants and dividend obligations given the net loss and cash outflow from operating activities ($5.9 million excluding restricted cash).